Matinas BioPharma Holdings Inc (MTNB) Page

Matinas BioPharma Holdings Inc (MTNB)

Matinas Biopharma Holdings is a biopharmaceutical company focused on development of its product candidate: MAT9001, a purified, prescription-only omega-3 free fatty acid formulation designed for the treatment of cardiovascular and metabolic conditions; and the application of its lipid nano-crystal (LNC) platform delivery technology to solve challenges relating to the delivery of small molecules, vaccines, proteins and peptides. Co.'s lead drug candidate based on the LNC platform delivery technology is MAT2203, which is an antifungal drug. Co.'s second clinical stage LNC-based product candidate is MAT2501, an orally administered formulation of aminoglycoside antibiotic amikacin.

MTNB — Key Stats (updated 3 HRs, 5 MINs ago)

Company Name:
Matinas BioPharma Holdings Inc
Website:
www.matinasbiopharma.com
Sector:
Drugs & Pharmaceuticals
Number of ETFs Holding MTNB:
2
Total Market Value Held by ETFs:
$1.64M
Total Market Capitalization:
$42.00M
% of Market Cap. Held by ETFs:
3.90%

MTNB — News

MTNB — Price Chart

MTNB — Current Quote

Quotes delayed 20 minutes

Free MTNB Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Avg. Broker Rec.

Strong Buy (4.00 out of 4)
100th percentile

(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

MTNB — Performance

Matinas BioPharma Holdings Inc (MTNB) Page | The Online Investor Page | www.TheOnlineInvestor.com

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.